Syed Rizvi

4.0k total citations · 1 hit paper
56 papers, 2.1k citations indexed

About

Syed Rizvi is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Immunology. According to data from OpenAlex, Syed Rizvi has authored 56 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Radiology, Nuclear Medicine and Imaging, 21 papers in Oncology and 17 papers in Immunology. Recurrent topics in Syed Rizvi's work include Radiopharmaceutical Chemistry and Applications (28 papers), Peptidase Inhibition and Analysis (13 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Syed Rizvi is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (28 papers), Peptidase Inhibition and Analysis (13 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Syed Rizvi collaborates with scholars based in Australia, United States and India. Syed Rizvi's co-authors include Barry Allen, Malini Raghavan, Yong Li, Chand Raja, Christos Apostolidis, Chang Qu, Tian Zhong, Fei Wen, Marie Ranson and Aliyah Morgenstern and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Syed Rizvi

56 papers receiving 2.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis

2020 459 citations Brett Hill, Syed Rizvi et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Syed Rizvi	769	656	517	445	354	56	2.1k
Yoshiaki Yura	455 0.6×	1.0k 1.5×	283 0.5×	568 1.3×	241 0.7×	172	2.7k
Sunil J. Advani	145 0.2×	717 1.1×	280 0.5×	619 1.4×	128 0.4×	55	1.8k
Shoichi Takahashi	152 0.2×	1.0k 1.6×	378 0.7×	430 1.0×	230 0.6×	166	4.6k
Stephan von Gunten	461 0.6×	1.5k 2.3×	1.7k 3.4×	284 0.6×	129 0.4×	73	3.0k
Ruey‐Long Hong	210 0.3×	847 1.3×	296 0.6×	1.5k 3.5×	808 2.3×	121	3.2k
Rita De Santis	398 0.5×	642 1.0×	1.2k 2.4×	339 0.8×	145 0.4×	82	2.3k
Alessandro Zerbini	558 0.7×	514 0.8×	1.6k 3.1×	1.1k 2.4×	235 0.7×	58	3.6k
J. David Beatty	1.2k 1.6×	708 1.1×	285 0.6×	965 2.2×	524 1.5×	92	3.2k
Erik H.J.G. Aarntzen	425 0.6×	834 1.3×	1.9k 3.7×	1.5k 3.4×	217 0.6×	109	3.2k
Janet M. Risk	84 0.1×	1.0k 1.6×	172 0.3×	482 1.1×	305 0.9×	82	2.5k

Countries citing papers authored by Syed Rizvi

Since Specialization

Citations

This map shows the geographic impact of Syed Rizvi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Syed Rizvi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Syed Rizvi more than expected).

Fields of papers citing papers by Syed Rizvi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Syed Rizvi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Syed Rizvi. The network helps show where Syed Rizvi may publish in the future.

Co-authorship network of co-authors of Syed Rizvi

This figure shows the co-authorship network connecting the top 25 collaborators of Syed Rizvi. A scholar is included among the top collaborators of Syed Rizvi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Syed Rizvi. Syed Rizvi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rizvi, Syed, et al.. (2025). Macrophage metabolic reprogramming during dietary stress influences adult body size in Drosophila. EMBO Reports. 26(22). 5397–5430. 1 indexed citations

Straalen, Kelsey R. van, Joseph Kirma, Christine M. Yee, et al.. (2024). Disease heterogeneity and molecular classification of inflammatory palmoplantar diseases. Journal of Allergy and Clinical Immunology. 154(5). 1204–1215.e9. 4 indexed citations

Hill, Brett, Syed Rizvi, Judy Chen, et al.. (2024). iGATE analysis improves the interpretability of single-cell immune landscape of influenza infection. JCI Insight. 9(12). 1 indexed citations

Billi, Allison C., Feiyang Ma, Olesya Plazyo, et al.. (2022). Nonlesional lupus skin contributes to inflammatory education of myeloid cells and primes for cutaneous inflammation. Science Translational Medicine. 14(642). eabn2263–eabn2263. 79 indexed citations

Abernathy‐Close, Lisa, Jasmine Stannard, Lam C. Tsoi, et al.. (2021). B Cell Signatures Distinguish Cutaneous Lupus Erythematosus Subtypes and the Presence of Systemic Disease Activity. Frontiers in Immunology. 12. 775353–775353. 29 indexed citations

Vasekar, Monali, Syed Rizvi, Xin Liu, Kent E. Vrana, & Hong Zheng. (2016). Novel Immunotherapies for Hematological Malignancies. Current Molecular Pharmacology. 9(3). 264–271. 21 indexed citations

Rizvi, Syed, Nasir Salam, Jie Geng, et al.. (2014). Distinct Assembly Profiles of HLA-B Molecules. The Journal of Immunology. 192(11). 4967–4976. 72 indexed citations

Song, Emma, Chang Qu, Syed Rizvi, et al.. (2008). Bismuth-213 radioimmunotherapy with C595 anti–MUC1 monoclonal antibody in an ovarian cancer ascites model. Cancer Biology & Therapy. 7(1). 76–80. 39 indexed citations

Rizvi, Syed, Emma Song, Chand Raja, et al.. (2008). Preparation and testing of bevacizumab radioimmunoconjugates with Bismuth-213 and Bismuth-205 / Bismuth-206. Cancer Biology & Therapy. 7(10). 1547–1554. 17 indexed citations

10.

Allen, Barry, Chand Raja, Syed Rizvi, et al.. (2005). Intralesional targeted alpha therapy for metastatic melanoma. Cancer Biology & Therapy. 4(12). 1318–1324. 96 indexed citations

11.

Qu, Chang, Yan Song, Syed Rizvi, et al.. (2005). In vivo and in vitro inhibition of pancreatic cancer growth by targeted alpha therapy using 213Bi-CHX.A”-C595. Cancer Biology & Therapy. 4(8). 848–853. 35 indexed citations

12.

Qu, Chang, Emma Song, Yong Li, et al.. (2005). Pre-clinical Study of 213Bi Labeled PAI2 for the Control of Micrometastatic Pancreatic Cancer. Clinical & Experimental Metastasis. 22(7). 575–586. 39 indexed citations

13.

Li, Yong, Syed Rizvi, Julie M. Blair, et al.. (2004). Antigenic expression of human metastatic prostate cancer cell lines for in vitro multiple-targeted α-therapy with 213Bi-conjugates. International Journal of Radiation Oncology*Biology*Physics. 60(3). 896–908. 22 indexed citations

14.

Rizvi, Syed, et al.. (2004). A Polypeptide Binding Conformation of Calreticulin Is Induced by Heat Shock, Calcium Depletion, or by Deletion of the C-Terminal Acidic Region. Molecular Cell. 15(6). 913–923. 65 indexed citations

15.

Allen, Barry, Chand Raja, Syed Rizvi, et al.. (2004). Targeted alpha therapy for cancer. Physics in Medicine and Biology. 49(16). 3703–3712. 49 indexed citations

16.

Li, Yong, Tian Zhong, Syed Rizvi, Neil H. Bander, & Barry Allen. (2002). In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen. Prostate Cancer and Prostatic Diseases. 5(1). 36–46. 76 indexed citations

17.

Shahbazi‐Gahrouei, Daryoush, et al.. (2002). In vitro studies of gadolinium-DTPA conjugated with monoclonal antibodies as cancer-specific magnetic resonance imaging contrast agents. Australasian Physical & Engineering Sciences in Medicine. 25(1). 31–38. 19 indexed citations

18.

Shahbazi‐Gahrouei, Daryoush, Meagan E. Williams, Syed Rizvi, & Barry Allen. (2001). In vivo studies of Gd‐DTPA‐monoclonal antibody and gd‐porphyrins: Potential magnetic resonance imaging contrast agents for melanoma. Journal of Magnetic Resonance Imaging. 14(2). 169–174. 62 indexed citations

19.

Allen, Barry, Syed Rizvi, Yong Li, Tian Zhong, & Marie Ranson. (2001). In vitro and preclinical targeted alpha therapy for melanoma, breast, prostate and colorectal cancers. Critical Reviews in Oncology/Hematology. 39(1-2). 139–146. 30 indexed citations

20.

Rizvi, Syed, Barry Allen, Tian Zhong, Gary Goozée, & Sarah Sarkar. (2001). In vitro and preclinical studies of targeted alpha therapy (TAT) for colorectal cancer. Colorectal Disease. 3(5). 345–353. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact